Miloš Pešek
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Molecular Biology
- Cancer Research top 5%
- Surgery
- Co-authors
- Jaromı́r RoubecMarek MinárikLucie BenešováOndřej FialaJindřich FínekOndřej TopolčanE. KaukelU. Gatzemeier
- Topics
- Lung Cancer Treatments and Mutations (62 papers)Lung Cancer Research Studies (31 papers)Colorectal Cancer Treatments and Studies (22 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaOsteoporosis International
In The Last Decade
Miloš Pešek
99 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.6k
- Molecular Biology 650
- Cancer Research 408
- Surgery 133
Countries citing papers authored by Miloš Pešek
This map shows the geographic impact of Miloš Pešek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloš Pešek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloš Pešek more than expected).
Fields of papers citing papers by Miloš Pešek
This network shows the impact of papers produced by Miloš Pešek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloš Pešek. The network helps show where Miloš Pešek may publish in the future.
Co-authorship network of co-authors of Miloš Pešek
This figure shows the co-authorship network connecting the top 25 collaborators of Miloš Pešek. A scholar is included among the top collaborators of Miloš Pešek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miloš Pešek. Miloš Pešek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | 8 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 0 | |
| 9 | 13 | |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 7 | |
| 13 | 30 | |
| 14 | 1 | |
| 15 | 18 | |
| 16 | 7 | |
| 17 | Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status. | 33 |
| 18 | 19 | |
| 19 | Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial | 41 |
| 20 | 15 |
About Miloš Pešek
Miloš Pešek is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 110 papers that have together received 2.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Research Studies (31 papers) and Colorectal Cancer Treatments and Studies (22 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Cancer Research (408 citations). Miloš Pešek has collaborated with scholars based in Czechia, Germany and Hungary. Frequent co-authors include Jaromı́r Roubec, Marek Minárik, Lucie Benešová, Ondřej Fiala, Jindřich Fínek, Ondřej Topolčan, E. Kaukel, U. Gatzemeier, A Płużańska and Rodryg Ramlau. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Osteoporosis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.